IMPL Impel NeuroPharma Inc.

1,397

$0.3693

$0.0502

(11.97%)

Today

Watchers	1,397
52-Wk Low	$0.19
52-Wk High	$4.20

Market Cap	$8.83M
Volume (M)	7,988.00
52-Wk High	$4.20
52-Wk Low	$0.19

Fundamentals

Impel Pharmaceuticals Announces Exploration of Strategic AlternativesGlobe Newswire • 2 months ago

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL) ( Impel or the Company ), a commercial-stage biopharmaceutical company with a mission to develop...

Share to Feed

JonesTrading Reaffirms Their Hold Rating on Impel Pharmaceuticals (IMPL)TipRanks Financial Blog • 3 months ago

JonesTrading analyst Sean Kim PhD maintained a Hold rating on Impel Pharmaceuticals (IMPL Research Report) today. The companys shares opened tod... JonesTrading analyst Sean Kim PhD maintained a Hold rating on Impel Pharmaceuticals (IMPL Resear...

JonesTrading downgrades Impel Pharmaceuticals (IMPL) to a HoldTipRanks Financial Blog • 4 months ago

Impel Pharmaceuticals (IMPL Research Report) received a Hold rating and price target from JonesTrading analyst Sean Kim PhD today. The companys ... Impel Pharmaceuticals (IMPL Research Report) received a Hold rating and price target from JonesTrading analyst...

Crude Oil Rises Sharply; Impel Pharmaceuticals Shares Spike HigherBenzinga • 5 months ago

U.S. stocks traded lower midway through trading, with the dropping over 50 points on Wednesday. The Dow traded down 0.17% to 34,361.31 while the NASDAQ fell 0.14% to 13,797.72. The S&P 500, also fell, dropping, 0.09% to 4,451.55. read more...

Thinking about buying stock in Workhorse Group, Canoo, Aurora Innovation, Plug Power, or Impel Pharmaceuticals?PR Newswire • 5 months ago

Thinking about buying stock in Workhorse Group, Canoo, Aurora Innovation, Plug Power, or Impel Pharmaceuticals? Thinking about buying stock in Workhorse Group, Canoo, Aurora Innovation, Plug Power, or Impel Pharmaceuticals? PR Newswire NEW YORK, July 5, 2023 NEW YORK, July 5, 2023 /PRNewswire...

Impel Pharmaceuticals to Present New Real-World Data for Trudhesa(R) at the 65th Annual Scientific Meeting of the American Headache SocietyGlobe Newswire • 6 months ago

Real-World Assessment Suggests that Concomitant Preventive and Acute Medication Use Decreases in Patients Using Trudhesa Additional Poster Underscores the Need for Non-Oral Treatment Options Given the Prevalence of Pre-Existing Gastrointestinal Disorders Among Those Prescribed Trudhesa SEATTLE, June...

JonesTrading Sticks to Its Buy Rating for Impel Pharmaceuticals (IMPL)TipRanks Financial Blog • 7 months ago

JonesTrading analyst Sean Kim PhD maintained a Buy rating on Impel Pharmaceuticals (IMPL Research Report) today and set a price target of $10.00.... JonesTrading analyst Sean Kim PhD maintained a Buy rating on Impel Pharmaceuticals (IMPL &#8211...

Impel Pharmaceuticals First Quarter 2023 Earnings: Misses ExpectationsSimply Wall St • 7 months ago

Impel Pharmaceuticals ( NASDAQ:IMPL ) First Quarter 2023 Results Key Financial Results Revenue: US$4.37m (up 149% from...

Recap: Impel Pharmaceuticals Q1 EarningsBenzinga • 7 months ago